Entrada Therapeutics, Inc. (NASDAQ:TRDA) Insider Sells $157,

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Nerissa Kreher sold 10,348 shares of the firm’s stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $15.19, for a total transaction of $157,186.12. Following the completion of the sale, the insider now owns 27,130 shares in the […]

Related Keywords

United States , America , Nerissa Kreher , Tower Research Capital , Nasdaq , America Corp , Cubist Systematic Strategies , Entrada Therapeutics Inc , Group Plc , Entrada Therapeutics , Get Free Report , Research Capital , General Group Plc , Systematic Strategies , Entrada Therapeutics Daily , Nasdaq Trda , Trda , Medical , Insider Trading , Nsider Trades , Stocks ,